The Implantable Cardioverter Defibrillator also known as ICD. It is battery-operated device which placed under the skin of patient to monitor the patient’s heart rate. They are connected to the heart by thin wires. If abnormal heart beat is detected ICD deliver an electric shock to reinstate a normal rhythm if the patient’s heart is beating fast.
The increase in prevalence of target diseases is the key driving factor which is expected to boost the global implantable cardioverter defibrillator market growth. Furthermore, increase in focus on providing public-access defibrillators as well as increase in training and awareness programs on defibrillator will positively contribute the market growth over the forecast period. Moreover, increase in reaserch and development activities will fuel the market growth. Also, continuous technological advancements will propel the global implantable cardioverter defibrillator market growth during this forecast period. For instance, in 2017, Biotronik had launched DX technology cardioverter defibrillator system in United State. It is specifically designed for heart failure patients. In addition to that, rise in demand for implantable cardiverter defibrillator in emerging nations such as like Asia Pacific, and MEA is expected to drive the market growth.
However, frequent product recalls is the major restraining factor which is expected to hinder the global implantable cardioverter defibrillator market growth. For instance, in 2023, FDA (Food and Drug Administration) had recalled Abbott’s implantable cardioverter defibrillator due to electric failures. Also, lack of awareness towards the advantages of using implantable defibrillator will affect the market growth.
Global Implantable Cardioverter Defibrillator Market is segmented into product type such as Single Chambered, Double Chambered, and Biventricular Implantable Cardioverter Defibrillator, by procedure type such as Trans-Venous Implantable Cardioverter Defibrillator, and Subcutaneous Implantable Cardioverter Defibrillator. Further, market is segmented into end user like Hospitals, Specialty Clinics, and Ambulatory Surgical Centers.
Also, Global Implantable Cardioverter Defibrillator Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Medtronic plc, LivaNova PLC Company, Mayo Clinic US, St. Jude Medical, Inc, MicroPort Scientific Corporation, MRI Interventions, Inc, Boston Scientific Corporation, CU Medical Systems, Koninklijke Philips N.V., and Mediana
By Product Type
Single Chambered Double Chambered Biventricular Implantable Cardioverter Defibrillator
By Procedure Type
Trans-Venous Implantable Cardioverter Defibrillator Subcutaneous Implantable Cardioverter Defibrillator
By End User
Hospitals Ambulatory Surgical Centers Specialty Clinics
By Region
North America Latin America Europe Asia Pacific Middle East & Africa
Key Questions Addressed by the Report
What are the Key Opportunities in Global Implantable Cardioverter Defibrillator Market? What will be the growth rate from 2023 to 2030? Which segment/region will have highest growth? What are the factors that will impact/drive the Market? What is the competitive Landscape in the Industry? What is the role of key players in the value chain? What are the strategies adopted by key players?
Global Implantable Cardioverter Defibrillator Market
1 Introduction 1.1 Objective of the Study 1.2 Market definition 1.3 Market Scope
2 Research Methodology
2.1 Data Mining 2.2 Validation 2.3 Primary Interviews 2.4 List of Data Sources
3 Executive Summary 4 Global Implantable Cardioverter Defibrillator Market Outlook 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis
5 Global Implantable Cardioverter Defibrillator Market, By Product Type 5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Implantable Cardioverter Defibrillator Market Share Analysis, By Product Type
5.3 Global Implantable Cardioverter Defibrillator Market Size and Forecast, By Product Type 5.3.1 Single Chambered
5.3.2. Double Chambered
5.3.3 Biventricular Implantable Cardioverter Defibrillator
6 Global Implantable Cardioverter Defibrillator Market, By Procedure Type 6.1 Y-o-Y Growth Comparison, By Procedure Type
6.2 Global Implantable Cardioverter Defibrillator Market Share Analysis, By Procedure Type
6.3 Global Implantable Cardioverter Defibrillator Market Size and Forecast, By Procedure Type 6.3.1Trans-Venous Implantable Cardioverter Defibrillator
6.3.2 Subcutaneous Implantable Cardioverter Defibrillator
7 Global Implantable Cardioverter Defibrillator Market, By End User 7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Implantable Cardioverter Defibrillator Market Share Analysis, By End User
7.3 Global Implantable Cardioverter Defibrillator Market Size and Forecast, By End User 7.3. 1 Hospitals & Ambulatory Centers
7.3.2. Ambulatory Surgical Centers
7.3.3. Specialty Clinics
8Global Implantable Cardioverter Defibrillator Market, By Region 8.1 Global Implantable Cardioverter Defibrillator Market Share Analysis, By Region
8.2 Global Implantable Cardioverter Defibrillator Market Share Analysis, By Region
8.3 Global Implantable Cardioverter Defibrillator Market Size and Forecast, By Region
9 North America Implantable Cardioverter Defibrillator Market Analysis and Forecast (2023-2030) 9.1 Introduction
9.2 North America Implantable Cardioverter Defibrillator Market Share Analysis, By Product Type
9.3 North America Implantable Cardioverter Defibrillator Market Size and Forecast, By Procedure Type
9.4 North America Implantable Cardioverter Defibrillator Market Size and Forecast, By End User
9.5 North America Implantable Cardioverter Defibrillator Market Size and Forecast, By Country
9.5.1 U.S. 9.5.2 Canada 9.5.3 Mexico
10EuropeImplantable Cardioverter Defibrillator Market Analysis and Forecast (2023-2030) 10.1 Introduction
10.2 Europe Implantable Cardioverter Defibrillator Market Share Analysis, By Product Type
10.3 Europe Implantable Cardioverter Defibrillator Market Size and Forecast, By Procedure Type
10.4 Europe Implantable Cardioverter Defibrillator Market Size and Forecast, By End User
10.5 Europe Implantable Cardioverter Defibrillator Market Size and Forecast, By Country
10.5.1 Germany 10.5.2 France 10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Implantable Cardioverter Defibrillator Market Analysis and Forecast (2023-2030) 11.1 Introduction
11.2 Asia Pacific Implantable Cardioverter Defibrillator Market Share Analysis, By Product Type
11.3 Asia Pacific Implantable Cardioverter Defibrillator Market Size and Forecast, By Procedure Type
11.4 Asia Pacific Implantable Cardioverter Defibrillator Market Size and Forecast, By End User
11.5 Asia Pacific Implantable Cardioverter Defibrillator Market Size and Forecast, By Country
11.5.1 China 11.5.2 Japan 11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Implantable Cardioverter Defibrillator Market Analysis and Forecast (2023-2030) 12.1 Introduction
12.2 Latin America Implantable Cardioverter Defibrillator Market Share Analysis, By Product Type
12.3 Latin America Implantable Cardioverter Defibrillator Market Size and Forecast, By Procedure Type
12.4 Latin America Implantable Cardioverter Defibrillator Market Size and Forecast, By End User
12.5 Latin America Implantable Cardioverter Defibrillator Market Size and Forecast, Country
13Middle East Implantable Cardioverter Defibrillator Market Analysis and Forecast (2023-2030) 13.1 Introduction
13.2 Middle East Implantable Cardioverter Defibrillator Market Share Analysis, By Product Type
13.3 Middle East Implantable Cardioverter Defibrillator Market Size and Forecast, By Procedure Type
13.4 Middle East Implantable Cardioverter Defibrillator Market Size and Forecast, By End User
13.5 Middle East Implantable Cardioverter Defibrillator Market Size and Forecast, By Country
14Competitive Analysis 14.1 Competition Dashboard 14.2 Market share Analysis of Top Vendors 14.3 Key Development Strategies
15Company Profiles
15.1 Medtronic PLC
15.1.1 Overview 15.1.2 Offerings 15.1.3 Key Financials 15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. LivaNova PLC Company
15.2.1 Overview 15.2.2 Offerings 15.2.3 Key Financials 15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Mayo Clinic US
15.3.1 Overview 15.3.2 Offerings 15.3.3 Key Financials 15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 St. Jude Medical, Inc
15.4.1 Overview 15.4.2 Offerings 15.4.3 Key Financials 15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 MicroPort Scientific Corporation
15.5.1 Overview 15.5.2 Offerings 15.5.3 Key Financials 15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 MRI Interventions, Inc 15.6.1 Overview 15.6.2 Offerings 15.6.3 Key Financials 15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Boston Scientific Corporation
15.7.1 Overview 15.7.2 Offerings 15.7.3 Key Financials 15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 CU Medical Systems
15.8.1 Overview 15.8.2 Offerings 15.8.3 Key Financials 15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Koninklijke Philips N.V
15.9.1 Overview 15.9.2 Offerings 15.9.3 Key Financials 15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Mediana
15.10.1 Overview 15.10.2 Offerings 15.10.3 Key Financials 15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
